Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Other financing activities (2016 - 2023)

Jaguar Health (JAGX) has disclosed Other financing activities for 7 consecutive years, with $6000.0 as the latest value for Q4 2023.

  • Quarterly Other financing activities changed N/A to $6000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$14000.0 through Jun 2024, down 100.53% year-over-year, with the annual reading at $1.2 million for FY2023, N/A changed from the prior year.
  • Other financing activities for Q4 2023 was $6000.0 at Jaguar Health, up from -$20000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.6 million in Q3 2019, with the low at -$1.6 million in Q4 2019.
  • Average Other financing activities over 4 years is $248272.7, with a median of $13000.0 recorded in 2020.
  • The sharpest move saw Other financing activities tumbled 102.33% in 2020, then skyrocketed 792.13% in 2023.
  • Over 4 years, Other financing activities stood at -$1.6 million in 2019, then skyrocketed by 201.08% to $1.6 million in 2020, then tumbled by 111.22% to -$178000.0 in 2022, then surged by 103.37% to $6000.0 in 2023.
  • According to Business Quant data, Other financing activities over the past three periods came in at $6000.0, -$20000.0, and $15000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.